• Natera, Fox Chase Cancer Center Partner for Oncology contractpharma
    August 21, 2018
    Natera, Inc. has partnered with Fox Chase Cancer Center, one of the leading cancer centers in the United States, to assess the company's Signatera™ (Research-Use Only) customized circulating tumor DNA (ctDNA) assay for recurrence monitoring of kidney canc
PharmaSources Customer Service